MacroGenics appoints Emil Kuriakose and Michael Vasconcelles as independent directors
MGNX•MacroGenics appointed Emil Kuriakose and Michael Vasconcelles as independent directors in late October 2026. Both are biopharmaceutical executives with oncology drug development experience.
1. Board appointments
MacroGenics appointed Emil Kuriakose and Michael Vasconcelles as independent directors in late October 2026. Both appointees are biopharmaceutical executives with extensive oncology drug development experience.
